RecruitingNCT07025031
Fetal Growth Restriction a Case Control Study
Maternal Serum Progesterone And Placental Heme Oxgenase-1 Expression In Early Onset Idiopathic Fetal Growth Restriction: A Case Control Study
Sponsor
National University of Malaysia
Enrollment
58 participants
Start Date
Jul 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to investigate the responsible factors that leads to idiopathic fetal growth restriction.
Eligibility
Sex: FEMALEMin Age: 19 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with idiopathic fetal growth restriction. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 19 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07025031